Product Dossier
STEMETIL
Product Dossier for STEMETIL (prochlorperazine mesilate, Atnahs Pharma). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Atnahs Pharma
- Active ingredient: prochlorperazine mesilate
- Therapeutic area: Neurology
- Same area: GILENYA
- Same area: RIVOTRIL
What it is
Stemetil is available as a prochlorperazine mesilate 12.5 mg per 1 mL injection ampoule and a prochlorperazine maleate 5 mg tablet.
PBS listing
The injection containing prochlorperazine mesilate 12.5 mg in 1 mL is listed on the PBS as 3 items with unrestricted access. The ex-manufacturer price is A$15.66.
Regulatory history
Stemetil was first registered on the ARTG on 21 October 1991, with both the injection and tablet formulations listed on that date.